Professor, Internal Medicine, Virginia Commonwealth University, Medical College of Virginia School of Medicine
Internal Medicine
Dr. Velimir A. Luketic, MD
|
|
Give Review
Dr. Velimir A. Luketic works in the field of Internal Medicine. He studied medicine at University of Alabama School of Medicine. University of Alabama School of Medicine is ranked 37/17 in Research/PrimaryCare. He has 1 awards "Fellow (FACG)". Velimir A. Luketic, MD is also published. He has 50 publications published. The lastest publication: "Nonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (-Cell) Function.' He accepts all Medicare patients.
Publications
- Evolution of the serum atherogenic risk in liver transplant recipients; role of lipoproteins, metabolic and inflammatory markers.
- A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel Disease.
- Nonalcoholic SteatoHepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (β-Cell) Function.
- Efficacy of Obeticholic Acid in Patients with Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid.
- Cognitive Reserve Is a Determinant of Health-related Quality of Life in Patients With Cirrhosis, Independent of Covert Hepatic Encephalopathy and Model for End-Stage L...
- Severity of Nonalcoholic Fatty Liver Disease and Progression to Cirrhosis Associate With Atherogenic Lipoprotein Profile.
- Covert Hepatic Encephalopathy Is Independently Associated With Poor Survival and Increased Risk of Hospitalization.
- Effects of Obstructive Sleep Apnea on Sleep Quality, Cognition, and Driving Performance in Patients with Cirrhosis.
- Validation of EncephalApp, Smartphone-based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy.
- Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with Cirrhosis.
- Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: Implications for the gut-liv...
- Diagnosis of Covert Hepatic Encephalopathy Without Specialized Tests.
- Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis.
- Differential Impact of Hyponatremia and Hepatic Encephalopathy on Health-Related Quality of Life and Brain Metabolite Abnormalities in Cirrhosis.
- The stroop smartphone APP is a short and valid method toscreen for minimal hepatic encephalopathy.
- Asymmetric Di-methyl Arginine is Strongly Associated with Cognitive Dysfunction and Brain MR Spectroscopic Abnormalities in Cirrhosis.
- Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation.
- Cognitive Performance as a predictor of hepatic encephalopathy in pre-transplant cirrhotic patients receiving psychoactive medications: A prospective study.
- Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography.
- Mild alcohol consumption is not associated with increased fibrosis in patients with chronic Hepatitis C.
- Similar progression of fibrosis between HIV/HCV-infected and HCV-infected patients: Analysis of paired liver biopsy samples.
- Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary Biliary cirrhosis.
- Incidence of prolonged length of stay after orthotopic liver transplantation and its influence on outcomes.
- Nonalcoholic steatoHepatitis is associated with altered hepatic MicroRNA expression.
- Prediction of clinical outcomes in primary Biliary cirrhosis by serum enhanced liver fibrosis assay.
- A single center review of the use of mycophenolate mofetil in the treatment of autoimmune Hepatitis.
- Steatohepatitis: Risk factors and impact on Disease severity in human immunodeficiency virus/hepatitis C virus coinfection.
- Surveillance for hepatocellular carcinoma in patients with Cirrhosis improves outcome.
- The impact of fat distribution on the severity of nonalcoholic fatty liver Disease and metabolic syndrome.
- Treatment of chronic Hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha.
- A prospective evaluation of fibrosis progression in patients with recurrent Hepatitis C virus following liver transplantation.
- Treatment of chronic Hepatitis C virus in African Americans with genotypes 2 and 3.
- Similarities and differences in outcomes of Cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.
- Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary Biliary cirrhosis.
- Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic Hepatitis C.
- The spectrum of chronic hepatitis C virus infection in the Virginia Correctional System: development of a strategy for the evaluation and treatment of inmates with HCV.
- A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatoHepatitis.
- Histologic recurrence of chronic Hepatitis C virus in patients after living donor and deceased donor liver transplantation.
- Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent Hepatitis C following liver transplantation.
- A comparison of the spectrum of chronic Hepatitis C virus between Caucasians and African Americans.
- Impact of highly active antiretroviral therapy on the spectrum of liver Disease in HCV-HIV coinfection.
- Treatment of chronic Hepatitis C virus in the virginia department of corrections: can compliance overcome racial differences to response?
- Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary Biliary cirrhosis.
- Nonalcoholic fatty liver Disease in patients with hepatitis C is associated with features of the metabolic syndrome.
- Hepatitis B virus genotypes in the United States: results of a nationwide study.
- Clinical and histologic spectrum of nonalcoholic fatty liver Disease associated with normal ALT values.
- Comparison of three commercially available assays for HCV RNA using the international unit standard: implications for management of patients with chronic Hepatitis C v...
- The clinical spectrum of Hepatitis C virus in HIV coinfection.
- Long term changes in liver histology following treatment of chronic Hepatitis C virus.
Schools
University Of Alabama School Of Medicine
Mayo Clinic Rochester
Med College Va
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Liver Biopsy
Conditions Treated
- Abdominal Pain
- Anemia
- Benign Neoplasm of the Digestive System
- Biliary Atresia
- View All
Doctors Specialties
- Gastroenterology
- Internal Medicine
Accepted Insurances
Awards
- Fellow (FACG)
Education
-
Virginia Commonwealth University Health System -
Mayo School of Graduate Medical Education -
University of Alabama School of Medicine
Drug Facts
| NPI NUMBER | 1811081128 | |
| NPPES Provider LastName | LUKETIC | |
| NPPES Provider FirstName | VELIMIR | |
| NPPES Provider ZIPCode | 232985051 | |
| NPPES Provider State | VA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 182.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1811081128 |
| Last Name Of The Provider | LUKETIC |
| First Name Of The Provider | VELIMIR |
| View All |
Similar Doctors
|
Dr. Sidney Jones, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rahul Ahuja, MD |
|
|
Dr. Monica R. Hazelrigg, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Souheil G. Abou-Assi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Iliana S. Bouneva, MD |
|
|
Dr. Alvin M. Zfass, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Robert K. Vincent, MD |
|
|
Dr. Vikas Goyal, MD |
|
|
Dr. Michael Fuchs, MD |
|
|
Dr. Keval A. Patel, MD |